Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes

NCT04962906 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

192

Enrollment

OTHER_GOV

Sponsor class

Conditions

COVID-19 Vaccines

Interventions

DRUG: Gam-COVID-Vac / Gam-COVID-Vac

Sponsor

Ministerio de Salud de Ciudad Autónoma de Buenos Aires